Filing Details
- Accession Number:
- 0001628280-25-029849
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-06 08:36:14
- Reporting Period:
- 2025-05-01
- Filing Date:
- 2025-06-06
- Accepted Time:
- 2025-06-06 08:36:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 1600 West End Ave. Suite 1300 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Transaction Summary
| Purchased: | 168 shares | Avg. Price: $5.11 | Total Value: $857.68 |
| Number of Shares After Transactions: | 5,699,260 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-01 | 8 | $4.86 | 5,699,100 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-02 | 8 | $4.75 | 5,699,108 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-05 | 8 | $4.68 | 5,699,116 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-06 | 8 | $4.60 | 5,699,124 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-07 | 8 | $4.71 | 5,699,132 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-08 | 8 | $4.50 | 5,699,140 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-09 | 8 | $4.78 | 5,699,148 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-12 | 8 | $5.25 | 5,699,156 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-13 | 8 | $5.67 | 5,699,164 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-14 | 8 | $5.68 | 5,699,172 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-15 | 8 | $5.20 | 5,699,180 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-16 | 8 | $5.37 | 5,699,188 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-19 | 8 | $4.92 | 5,699,196 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-20 | 8 | $5.41 | 5,699,204 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-21 | 8 | $5.05 | 5,699,212 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-22 | 8 | $5.10 | 5,699,220 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-23 | 8 | $5.14 | 5,699,228 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-27 | 8 | $5.27 | 5,699,236 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-28 | 8 | $5.68 | 5,699,244 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-29 | 8 | $5.66 | 5,699,252 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-05-30 | 8 | $4.93 | 5,699,260 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
Billionaire Hedge Funds
